Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.26.1 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.26.1 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.5 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.5 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.108 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.108 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.29NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.29NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.2.29NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.2.29NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
N.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
N.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
P.1.15 (Gamma)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
P.1.15 (Gamma)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.348NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-13865.4China
B.1.1.348NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.575NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.575NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.32 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.32 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.46.3 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.46.3 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.4.6 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.4.6 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.75.2 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.75.2 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
C.37 (Lambda)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
C.37 (Lambda)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
P.1.14 (Gamma)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
P.1.14 (Gamma)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CR.1.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CR.1.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
DV.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DV.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BT.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BT.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-17507.2China
BE.1.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BE.1.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FS.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FS.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.5.54NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.5.54NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.122.4 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.122.4 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.101 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.101 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.1.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.1.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.1.14NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.1.14NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used